衰老对多巴胺系统的神经生物学影响:综合性综述
Gabriel S Rocha1, Marco Aurelio M Freire1, Karina M Paiva2
1Behavioral and Evolutionary Neurobiology Laboratory, Federal University of Sergipe (UFS), Itabaiana, Brazil.
Journal of chemical neuroanatomy
|March 23, 2024
概括
衰老 (衰老) 影响大脑的多巴胺系统,影响关键功能. 本综述详细介绍了衰老如何改变特定的多巴胺通路 (A8-A17) 和它们的作用.
科学领域:
- 神经科学是一个神经科学.
- 衰老研究研究 衰老研究
- 神经生物学 神经生物学 神经生物学
背景情况:
- 衰老是一种自然的衰老过程,影响分子,细胞和微观解剖学水平.
- 大脑非常容易衰老,可能会损害其功能.
- 多巴胺是一种关键的神经递质,调节中枢神经系统的重要功能.
研究的目的:
- 审查衰老对多巴胺基系统的影响.
- 专注于因衰老而导致的多巴胺基核 (A8-A17) 的解剖和功能变化.
主要方法:
- 关于衰老和多巴胺系统研究的文献综述.
- 对多巴胺基核的解剖学和功能数据的分析 (A8-A17).
主要成果:
- 衰老会导致多巴胺基系统的显著变化.
- 详细介绍了衰老对核A8-A17的解剖学和功能的具体影响.
结论:
- 衰老严重影响大脑的多巴胺基系统.
- 了解多巴胺通路中的这些与年龄相关的变化对于解决认知和运动衰退至关重要.
更多相关视频
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Aging
49
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
49
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K


